These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 12962166

  • 21. Cethromycin: a promising new ketolide antibiotic for respiratory infections.
    Rafie S, MacDougall C, James CL.
    Pharmacotherapy; 2010 Mar; 30(3):290-303. PubMed ID: 20180612
    [Abstract] [Full Text] [Related]

  • 22. Clinical efficacy of ketolides in the treatment of respiratory tract infections.
    Reinert RR.
    J Antimicrob Chemother; 2004 Jun; 53(6):918-27. PubMed ID: 15117934
    [Abstract] [Full Text] [Related]

  • 23. Telithromycin: the first of the ketolides.
    Shain CS, Amsden GW.
    Ann Pharmacother; 2002 Mar; 36(3):452-64. PubMed ID: 11895060
    [Abstract] [Full Text] [Related]

  • 24. [Telithromycin: a new therapeutic option for community-acquired respiratory infection].
    Muñoz MJ, Azanza JR, Escolar M, Macaya A, Gil FJ.
    Rev Med Univ Navarra; 2002 Mar; 46(3):37-44. PubMed ID: 12685116
    [No Abstract] [Full Text] [Related]

  • 25. Ketolides in the treatment of respiratory infections.
    Zhanel GG, Hoban DJ.
    Expert Opin Pharmacother; 2002 Mar; 3(3):277-97. PubMed ID: 11866679
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Clinical use of antimicrobial pharmacodynamic profiles to optimise treatment outcomes in community-acquired bacterial respiratory tract infections: application to telithromycin.
    Nicolau DP.
    Expert Opin Pharmacother; 2004 Feb; 5(2):229-35. PubMed ID: 14996620
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Telithromycin: a ketolide antibiotic for treatment of respiratory tract infections.
    Lonks JR, Goldmann DA.
    Clin Infect Dis; 2005 Jun 01; 40(11):1657-64. PubMed ID: 15889365
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Telithromycin (Ketek) for respiratory infections.
    Med Lett Drugs Ther; 2004 Aug 16; 46(1189):66-8. PubMed ID: 15314586
    [No Abstract] [Full Text] [Related]

  • 32. Drugs of the 21st century: telithromycin (HMR 3647)--the first ketolide.
    Ackermann G, Rodloff AC.
    J Antimicrob Chemother; 2003 Mar 16; 51(3):497-511. PubMed ID: 12615850
    [Abstract] [Full Text] [Related]

  • 33. Pharmacodynamic rationale for short-duration antibacterial therapy.
    Nicolau DP.
    J Infect; 2002 Feb 16; 44 Suppl A():17-23. PubMed ID: 12150491
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Safeguarding future antimicrobial options: strategies to minimize resistance.
    Leclercq R.
    Clin Microbiol Infect; 2001 Feb 16; 7 Suppl 3():18-23. PubMed ID: 11523557
    [Abstract] [Full Text] [Related]

  • 39. The rise of fluoroquinolone resistance: fact or fiction.
    Ferraro MJ.
    J Chemother; 2002 Jul 16; 14 Suppl 3():31-41. PubMed ID: 12418559
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.